MX2020008695A - Composicion granular, metodo de produccion para composicion granular y metodo para mejorar la propiedad de disolucion para composicion granular. - Google Patents

Composicion granular, metodo de produccion para composicion granular y metodo para mejorar la propiedad de disolucion para composicion granular.

Info

Publication number
MX2020008695A
MX2020008695A MX2020008695A MX2020008695A MX2020008695A MX 2020008695 A MX2020008695 A MX 2020008695A MX 2020008695 A MX2020008695 A MX 2020008695A MX 2020008695 A MX2020008695 A MX 2020008695A MX 2020008695 A MX2020008695 A MX 2020008695A
Authority
MX
Mexico
Prior art keywords
granular composition
producing
elution property
compression
improving elution
Prior art date
Application number
MX2020008695A
Other languages
English (en)
Inventor
Toshinori Tanaka
Rie Yamada
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Publication of MX2020008695A publication Critical patent/MX2020008695A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Glanulating (AREA)

Abstract

Se proporciona un método de producción para una composición granular en el que se mejora la propiedad de disolución de 2-{4-[N -(5,6-difenilpiradin-2-il)-N- isopropilamino]butiloxi}-N-( metilsulfonil)acetamida. El método de producción para una composición granular incluye una etapa de moldeo por compresión de una mezcla obtenida por mezcla de 2-{4-[N-(5,6-difenilpiradin-2 -il)-N- isopropilamino]butiloxi}-N-(metilsulfonil)acetamida y al menos uno o más excipientes seleccionados del grupo que consiste en un alcohol de azúcar, un almidón y un sacárido, obteniendo así un material moldeado por compresión.
MX2020008695A 2018-02-21 2019-02-20 Composicion granular, metodo de produccion para composicion granular y metodo para mejorar la propiedad de disolucion para composicion granular. MX2020008695A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2018029093 2018-02-21
PCT/JP2019/006317 WO2019163822A1 (ja) 2018-02-21 2019-02-20 粒状組成物、粒状組成物の製造方法、および粒状組成物の溶出性改善方法

Publications (1)

Publication Number Publication Date
MX2020008695A true MX2020008695A (es) 2020-09-25

Family

ID=67687749

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020008695A MX2020008695A (es) 2018-02-21 2019-02-20 Composicion granular, metodo de produccion para composicion granular y metodo para mejorar la propiedad de disolucion para composicion granular.

Country Status (21)

Country Link
US (1) US20200397700A1 (es)
EP (1) EP3756670A4 (es)
JP (2) JP7430629B2 (es)
KR (1) KR20200123447A (es)
CN (1) CN112055591A (es)
AR (1) AR114399A1 (es)
AU (1) AU2019225516A1 (es)
BR (1) BR112020016230A2 (es)
CA (1) CA3091584A1 (es)
CL (1) CL2020002129A1 (es)
CO (1) CO2020011034A2 (es)
EC (1) ECSP20057951A (es)
IL (1) IL276732A (es)
MA (1) MA51913A (es)
MX (1) MX2020008695A (es)
PE (1) PE20210448A1 (es)
PH (1) PH12020551285A1 (es)
RU (1) RU2020130411A (es)
SG (1) SG11202007967YA (es)
TW (1) TW201936175A (es)
WO (1) WO2019163822A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3154802A1 (en) * 2019-10-23 2021-04-29 Marc Patrik SCHRADER Pharmaceutical composition comprising selexipag
WO2021206159A1 (ja) * 2020-04-10 2021-10-14 日本新薬株式会社 固形製剤及びその製造方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2654197B2 (ja) * 1989-09-25 1997-09-17 三菱電機株式会社 スターリングエンジンの圧縮機駆動装置
WO2002024168A1 (fr) * 2000-09-25 2002-03-28 Nippon Shinyaku Co., Ltd. Procede de production d'une dispersion solide medicinale
TWI316055B (es) 2001-04-26 2009-10-21 Nippon Shinyaku Co Ltd
ATE405170T1 (de) * 2003-05-06 2008-09-15 Gumlink As Methode zur herstellung von kaugummigranulat und komprimierten kaugummiprodukten, sowie ein kaugummigranuliersystem
GB0423103D0 (en) * 2004-10-19 2004-11-17 Boots Healthcare Int Ltd Therapeutic agents
PL2447254T3 (pl) * 2009-06-26 2018-05-30 Nippon Shinyaku Co., Ltd. Kryształy
AU2016366073B2 (en) 2015-12-02 2021-08-26 Nippon Shinyaku Co., Ltd. Pharmaceutical composition containing 2-{4-[N-(5,6- diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}-N- (methylsulfonyl)acetamide
WO2017121806A1 (en) * 2016-01-15 2017-07-20 Sandoz Ag Pharmaceutical composition of selexipag

Also Published As

Publication number Publication date
EP3756670A4 (en) 2021-11-03
BR112020016230A2 (pt) 2020-12-08
PE20210448A1 (es) 2021-03-08
MA51913A (fr) 2020-12-30
RU2020130411A (ru) 2022-03-21
CN112055591A (zh) 2020-12-08
WO2019163822A1 (ja) 2019-08-29
JPWO2019163822A1 (ja) 2021-02-04
JP2023182650A (ja) 2023-12-26
US20200397700A1 (en) 2020-12-24
CA3091584A1 (en) 2019-08-29
ECSP20057951A (es) 2020-10-30
CO2020011034A2 (es) 2020-12-10
AR114399A1 (es) 2020-09-02
CL2020002129A1 (es) 2021-02-05
JP7430629B2 (ja) 2024-02-13
TW201936175A (zh) 2019-09-16
AU2019225516A1 (en) 2020-10-08
PH12020551285A1 (en) 2021-05-31
IL276732A (en) 2020-09-30
RU2020130411A3 (es) 2022-03-21
EP3756670A1 (en) 2020-12-30
SG11202007967YA (en) 2020-09-29
KR20200123447A (ko) 2020-10-29

Similar Documents

Publication Publication Date Title
PH12020551285A1 (en) Granular composition, production method for granular composition, and dissolution property improvement method for granular composition
MY141178A (en) Injection/compression molding method for conductive thermoplastic resin composition
MX2013007072A (es) Composiciones a base de propileno con aspecto mejorado y excelente fluidez en el molde.
MX2014013030A (es) Procedimiento de produccion de cuerpos moldeados de espuma.
PH12018000059A1 (en) Process for the manufacture of wood composite materials as well as wood composite materials obtainable by the process
EP1389514A8 (en) Tablet, process for producing the same, and molded article obtained therefrom
WO2011020680A3 (de) Verfahren zur herstellung von lederpellets und compound-granulat sowie dessen verwendung
MY185274A (en) Method for synthesizing nanoscale zsm-5 molecular sieve
BR112017016004A2 (pt) ?método para produzir um produto moldado por injeção, e, uso de fibras de casca de semente de girassol?
BR112021016647A2 (pt) Corpo sinterizado moldado, e método para a produção de corpo sinterizado moldado
SA519401335B1 (ar) طريقة لإنتاج كريات، طريقة لإنتاج منتج راتنجي مشكل بالقولبة، وكريات
MX2019013457A (es) Sistema de fabricacion de hielo compactado.
ATE475520T1 (de) Dosiermaschine für korkgranulat zur herstellung agglomerierter pfropfen
FI20185787A1 (fi) Menetelmä valukappaleiden valmistamiseksi
CN109567070A (zh) 一种针叶樱桃海参复合咀嚼片及其制备方法
WO2008133214A1 (ja) 熱可塑性樹脂組成物及びその製造方法並びに成形体の製造方法
RU2007148836A (ru) Способ изготовления нанокомпозиционного материала
Xian-Lin et al. Effects of reclaiming and cultivation in marshland on Oncomelania snail control
Kleinebudde et al. Roll Compaction/Dry Granulation of Pharmaceutical Excipients: Case Study Magnesium Carbonate
CN103330693B (zh) 提高崩解性的辛伐他汀组合物及其制备方法
MY140808A (en) Method for producing a semiconductor-molding tablet
RU2454382C1 (ru) Арболитовая смесь
PL410119A1 (pl) Sposób wytwarzania innowacyjnej biomasy stałej pod postacią granulatu przy wykorzystaniu energii z OZE
GB445208A (en) Process for the manufacture of agglomerates of carbonaceous material without addition of pitch
TH12606C3 (th) กรรมวิธีการผลิตเชื้อเพลิงจากขยะ (Refuse Derived Fuel or RDF) ผสมกะลาปาล์ม